Scilex Holding (SCLX) Assets (2020 - 2026)
Scilex Holding (SCLX) posted Assets of $253.6 million for Q2 2026, down 13.65% on a QoQ basis from $293.6 million in Q1 2026, and up 202.74% year-over-year from $83.8 million in Q2 2025.
Analysis
Scilex Holding (SCLX) Assets (2020 - 2026) Analysis & Trends
Scilex Holding has reported Assets for 7 years, with the latest figure at $253.6 million in Q2 2026.
- On a quarterly basis, Assets rose 202.74% year-over-year to $253.6 million in Q2 2026; TTM through Jun 2026 was $253.6 million, a 202.74% increase from a year earlier, with the FY2025 full-year figure at $365.0 million, up 292.65% from the prior year.
- Assets was $253.6 million for Q2 2026 at Scilex Holding, down from $293.6 million in the prior quarter.
- The five-year high for Assets was $365.0 million in Q4 2025, with the low at $79.0 million in Q1 2025.
- Average Assets over 5 years is $144.8 million, with a median of $101.4 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Assets slumped 38.96% in 2023, then jumped 292.65% in 2025.
- Over 5 years, Assets stood at $86.5 million in 2022, then increased by 17.08% to $101.3 million in 2023, then fell by 8.25% to $93.0 million in 2024, then surged by 292.65% to $365.0 million in 2025, then plunged by 30.53% to $253.6 million in 2026.
- The last three Assets figures came in at $253.6 million (Q2 2026), $293.6 million (Q1 2026), and $365.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 150.01 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 4.32 Bn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 7.87 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 7.22 Bn |
| 10 | Scilex Holding | 38.06 Mn | -76.90 Mn | 3.97 Mn | 253.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 253.56 Mn |
| Mar 31, 2026 | 293.64 Mn |
| Dec 31, 2025 | 364.98 Mn |
| Sep 30, 2025 | 275.88 Mn |
| Jun 30, 2025 | 83.76 Mn |
| Mar 31, 2025 | 78.98 Mn |
| Dec 31, 2024 | 92.95 Mn |
| Sep 30, 2024 | 100.43 Mn |
| Jun 30, 2024 | 104.54 Mn |
| Mar 31, 2024 | 91.24 Mn |
| Dec 31, 2023 | 101.31 Mn |
| Sep 30, 2023 | 80.53 Mn |
| Jun 30, 2023 | 126.46 Mn |
| Mar 31, 2023 | 86.05 Mn |
| Dec 31, 2022 | 86.53 Mn |
| Sep 30, 2022 | 101.46 Mn |
| Jun 30, 2022 | 142.30 Mn |
| Mar 31, 2022 | 140.97 Mn |
| Dec 31, 2021 | 77.93 Mn |
| Sep 30, 2021 | 139.64 Mn |